Medi Assist Healthcare Services Ltd

- The company has an enabling resolution at the board level valid for 12 months for fundraising but has not announced any timing, quantum, or usage details yet. - Any developments regarding fundraising will be communicated to shareholders and the public as they occur. - Currently, the company carries normal course debt of approximately Rs. 460+ crores on its balance sheet, including Rs. 1 crore of working capital overdraft. - The management indicated no immediate fundraising activity but remains open to updates in the coming quarters. - Dividend decisions have been deferred, with the board planning to revisit capital allocation and growth investment needs in the subsequent quarter.

- The company continues to invest annually about 5% to 7% of revenues in technology to build core differentiation and innovation (Page 6). - Investments focus on enabling unbundling of services, enabling new SaaS offerings and platform businesses that leverage existing capabilities (Page 10-11). - These technology investments have proven track records with payout in enhanced monetization, insurance company recognition, and potential for operating leverage (Page 11). - Acquisition strategy remains targeted and strategic, such as the recent Paramount TPA acquisition to build a pan-India platform and strengthen insurer relationships (Page 14). - No specific future capital raise timing or quantum has been announced yet; the board keeps an enabling resolution for fundraise valid for 12 months (Page 13). - Dividend decisions and further capital allocation will be reviewed in subsequent quarters based on growth and capital needs (Page 13).

- Growth driven by expansion in both group and retail segments, with group premiums growing 12.4% FY '24 to FY '25 vs industry 10.5%, and retail premiums growing 29.4% vs industry 12.2%. - Focus on evolving from a pure TPA to a health benefits administrator with unbundled SaaS and technology offerings to increase revenue streams. - Increasing adoption of add-on/top-up voluntary products in group insurance, improving revenue per life. - Growing technology contracts (~1.5%-2% of revenues) with SaaS models expected to scale up as insurers see value in unbundled services. - Continued investments in technology for fraud detection and cashless network to create value and enable higher revenue. - Market leadership with 30.3% group market share and high retention rates (95%) supporting sustained growth. - Outlook cautious on employment-driven volume growth but optimism on benefits expansion and new insurance product integration. - No explicit near-term revenue split or volume guidance, but internally tracking revenue per life and premium yields closely.

- Medi Assist expects continued growth driven by evolving from a pure TPA model to a health benefits administrator, focusing on unbundled, technology-driven services (Page 17). - Revenue growth is anticipated from expanding SaaS contracts and new technology offerings like fraud detection, with evolving pricing models (Page 17). - Group premium under management grew 12.4% vs. industry 10.5%, and retail grew 29.4% vs. industry 12.2%, indicating above-industry growth momentum (Page 7). - Profit margins are improving, with FY25 EBITDA margin at 21.3% and a 15.6% YOY growth; PAT margin improved to 12.3% with 28.5% YOY growth in PAT (Page 8). - Caution on volume growth: Lives growth slowing to about 50% of prior levels, but premium and benefit expansion support revenue (Pages 14–15). - The company aims for sustained cash flow generation and profitability; dividend decisions deferred pending capital allocation needs (Pages 13–14). - Growth will also be value-driven through cost savings and innovations in fraud prevention and cashless solutions, not solely premium market share (Pages 12–13). Overall, Medi Assist projects steady earnings and operational profit growth through technology integration, market share gains, and expanded service offerings.

The transcript provided from Medi Assist Healthcare Services Limited does not explicitly mention the current or expected order book or pending orders. However, the following related points can be noted: - The company has recently received regulatory approval to acquire 100% equity in Paramount Health Services & Insurance TPA Private Limited, indicating strategic expansion. - Medi Assist continues to build partnerships and grow in the third-party administration (TPA) and health benefits administration market, with a focus on unbundling services and technology. - The company reports strong premium under management (over ₹20,000 crore) with growth in both group and retail segments. - They highlight growth in new contracts related to SaaS technology models and unbundled services beyond traditional TPA contracts. - The outlook appears focused on continued growth through acquisitions, technology integration, and expanded insurer partnerships. No specific figures on the order book or pending orders are disclosed in the transcript.